Witnesses Seek 15% Boost For NCI In 1998 as First Step to 100% Raise Over 5 Years
In Brief: visco Named to Cancer Policy Board; Foundation Pledges $6.5 Million to Karmanos
In This Issue: Congressional Testimony On NIH, NCI Appropriations, FDA Reform
Patient Advocates; NBCC Delivers 2.6M Signatures, demands 2.6Billion
NIH director; Targets Increases Favor Established Researchers
Pharmaceutical Industry: IVAX Official Broder Objects To Orphan Drug Policies of FDA
National Academy elects New Members
Trending Stories
- Knight Cancer Institute receives record-setting $2B gift from the Knights—and self-governance within OHSU
Brian Druker returns to executive role as president of the new Knight Cancer Group - Banished from the institute he founded, separated from his lab materials, Tom Curran sues Children’s Mercy
Whistleblower lawsuit alleges wrongful firing - ACOG says it will no longer accept federal funding
- Lou Weiner: Poetry and art help us imagine my mother’s world as a hidden child of the Holocaust
- When public service ends abruptly, do books provide solace? An escape? Perspective?
Former NIH and FDA employees tell us what they are reading in 2025 - All federal grants must be reviewed by Trump appointees, executive order directs